Avenue Therapeutics Inc. (NASDAQ: ATXI)
$3.57
+0.0800 ( +2.29% ) 7.9K
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
Market Data
Open
$3.57
Previous close
$3.49
Volume
7.9K
Market cap
$3.18M
Day range
$3.41 - $3.72
52 week range
$3.21 - $91.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 12, 2023 |
4 | Insider transactions | 1 | Sep 12, 2023 |
8-k | 8K-related | 14 | Sep 08, 2023 |
10-q | Quarterly Reports | 50 | Aug 11, 2023 |
8-k | 8K-related | 15 | Aug 10, 2023 |
8-k | 8K-related | 12 | Jul 21, 2023 |
8-k | 8K-related | 13 | Jul 05, 2023 |
4 | Insider transactions | 1 | Jul 05, 2023 |
4 | Insider transactions | 1 | Jul 05, 2023 |
4 | Insider transactions | 1 | Jul 05, 2023 |